Literature DB >> 26824643

Mimicking of Arginine by Functionalized N(ω)-Carbamoylated Arginine As a New Broadly Applicable Approach to Labeled Bioactive Peptides: High Affinity Angiotensin, Neuropeptide Y, Neuropeptide FF, and Neurotensin Receptor Ligands As Examples.

Max Keller1, Kilian K Kuhn1, Jürgen Einsiedel2, Harald Hübner2, Sabrina Biselli1, Catherine Mollereau3, David Wifling1, Jaroslava Svobodová1, Günther Bernhardt1, Chiara Cabrele4, Patrick M L Vanderheyden5, Peter Gmeiner2, Armin Buschauer1.   

Abstract

Derivatization of biologically active peptides by conjugation with fluorophores or radionuclide-bearing moieties is an effective and commonly used approach to prepare molecular tools and diagnostic agents. Whereas lysine, cysteine, and N-terminal amino acids have been mostly used for peptide conjugation, we describe a new, widely applicable approach to peptide conjugation based on the nonclassical bioisosteric replacement of the guanidine group in arginine by a functionalized carbamoylguanidine moiety. Four arginine-containing peptide receptor ligands (angiotensin II, neurotensin(8-13), an analogue of the C-terminal pentapeptide of neuropeptide Y, and a neuropeptide FF analogue) were subject of this proof-of-concept study. The N(ω)-carbamoylated arginines, bearing spacers with a terminal amino group, were incorporated into the peptides by standard Fmoc solid phase peptide synthesis. The synthesized chemically stable peptide derivatives showed high receptor affinities with Ki values in the low nanomolar range, even when bulky fluorophores had been attached. Two new tritiated tracers for angiotensin and neurotensin receptors are described.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26824643     DOI: 10.1021/acs.jmedchem.5b01495

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  Modifications at Arg and Ile Give Neurotensin(8-13) Derivatives with High Stability and Retained NTS1 Receptor Affinity.

Authors:  Lisa Schindler; Günther Bernhardt; Max Keller
Journal:  ACS Med Chem Lett       Date:  2019-05-10       Impact factor: 4.345

2.  Prototypic 18F-Labeled Argininamide-Type Neuropeptide Y Y1R Antagonists as Tracers for PET Imaging of Mammary Carcinoma.

Authors:  Max Keller; Simone Maschauer; Albert Brennauer; Philipp Tripal; Norman Koglin; Ralf Dittrich; Günther Bernhardt; Torsten Kuwert; Hans-Jürgen Wester; Armin Buschauer; Olaf Prante
Journal:  ACS Med Chem Lett       Date:  2017-02-21       Impact factor: 4.345

3.  Differently fluorescence-labelled dibenzodiazepinone-type muscarinic acetylcholine receptor ligands with high M2R affinity.

Authors:  Corinna G Gruber; Andrea Pegoli; Christoph Müller; Lukas Grätz; Xueke She; Max Keller
Journal:  RSC Med Chem       Date:  2020-06-08

4.  An Alkyne-functionalized Arginine for Solid-Phase Synthesis Enabling "Bioorthogonal" Peptide Conjugation.

Authors:  Katrin Spinnler; Lara von Krüchten; Adam Konieczny; Lisa Schindler; Günther Bernhardt; Max Keller
Journal:  ACS Med Chem Lett       Date:  2019-09-30       Impact factor: 4.345

5.  Structural basis of ligand binding modes at the neuropeptide Y Y1 receptor.

Authors:  Zhenlin Yang; Shuo Han; Max Keller; Anette Kaiser; Brian J Bender; Mathias Bosse; Kerstin Burkert; Lisa M Kögler; David Wifling; Guenther Bernhardt; Nicole Plank; Timo Littmann; Peter Schmidt; Cuiying Yi; Beibei Li; Sheng Ye; Rongguang Zhang; Bo Xu; Dan Larhammar; Raymond C Stevens; Daniel Huster; Jens Meiler; Qiang Zhao; Annette G Beck-Sickinger; Armin Buschauer; Beili Wu
Journal:  Nature       Date:  2018-04-18       Impact factor: 49.962

6.  A split luciferase-based probe for quantitative proximal determination of Gαq signalling in live cells.

Authors:  Timo Littmann; Takeaki Ozawa; Carsten Hoffmann; Armin Buschauer; Günther Bernhardt
Journal:  Sci Rep       Date:  2018-11-21       Impact factor: 4.379

7.  In Search of NPY Y4R Antagonists: Incorporation of Carbamoylated Arginine, Aza-Amino Acids, or d-Amino Acids into Oligopeptides Derived from the C-Termini of the Endogenous Agonists.

Authors:  Kilian K Kuhn; Timo Littmann; Stefanie Dukorn; Miho Tanaka; Max Keller; Takeaki Ozawa; Günther Bernhardt; Armin Buschauer
Journal:  ACS Omega       Date:  2017-07-14

8.  Fluorescence Labeling of Neurotensin(8-13) via Arginine Residues Gives Molecular Tools with High Receptor Affinity.

Authors:  Max Keller; Shahani A Mahuroof; Vivyanne Hong Yee; Jessica Carpenter; Lisa Schindler; Timo Littmann; Andrea Pegoli; Harald Hübner; Günther Bernhardt; Peter Gmeiner; Nicholas D Holliday
Journal:  ACS Med Chem Lett       Date:  2019-11-19       Impact factor: 4.345

9.  Neurotensin analogs by fluoroglycosylation at Nω-carbamoylated arginines for PET imaging of NTS1-positive tumors.

Authors:  Lisa Schindler; Katrin Wohlfahrt; Lara Gluhacevic von Krüchten; Olaf Prante; Max Keller; Simone Maschauer
Journal:  Sci Rep       Date:  2022-09-02       Impact factor: 4.996

10.  Development of a Neurotensin-Derived 68Ga-Labeled PET Ligand with High In Vivo Stability for Imaging of NTS1 Receptor-Expressing Tumors.

Authors:  Lisa Schindler; Jutta Moosbauer; Daniel Schmidt; Thilo Spruss; Lukas Grätz; Steffen Lüdeke; Frank Hofheinz; Sebastian Meister; Bernd Echtenacher; Günther Bernhardt; Jens Pietzsch; Dirk Hellwig; Max Keller
Journal:  Cancers (Basel)       Date:  2022-10-08       Impact factor: 6.575

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.